Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.

作者: Junli Deng , Li Wang , Jie Ni , Julia Beretov , Valerie Wasinger

DOI: 10.1080/14789450.2016.1233065

关键词: MedicineBiomarker (medicine)Ovarian cancerBiomarker discoveryBioinformaticsPotential biomarkersProteomicsChemotherapeutic response

摘要: ABSTRACTIntroduction: Chemoresistance is a major challenge to current ovarian cancer chemotherapy. It important identify biomarkers distinguish chemosensitive and chemoresistant patients.Areas covered: We review the medical literature, discuss MS-based technologies with respect summarize promising identified. In addition, challenges future perspectives of biomarker discovery research are explored. With employment mass spectrometry-based (MS-based) proteomics, has made great progress in last decade. Many potential were identified by proteomics technologies, some which have been validated for further extensive studies clinical settings.Expert commentary: The newly developing area may provide clue predicting chemotherapeutic response discover therapeutic targets paving way personalize...

参考文章(77)
Kenneth R. Schulz, Erika A. Danna, Peter O. Krutzik, Garry P. Nolan, Single-cell phospho-protein analysis by flow cytometry. Current protocols in immunology. ,vol. 96, ,(2007) , 10.1002/0471142735.IM0817S96
Jian-Yang Zhang, Feng Ye, Yun-Feng Fu, Cai-Yun Zhou, Wei-Guo Lu, Xiao-Dong Cheng, Xing Xie, Song-Fa Zhang, Xin-Yu Wang, Zhi-Qin Fu, Qiao-Hua Peng, TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer. Autophagy. ,vol. 11, pp. 225- 238 ,(2015) , 10.1080/15548627.2014.998931
Ming Chen, Hong Huang, Haojie He, Wantao Ying, Xin Liu, Zhiqin Dai, Jie Yin, Ning Mao, Xiaohong Qian, Lingya Pan, Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines Cancer Science. ,vol. 106, pp. 1075- 1083 ,(2015) , 10.1111/CAS.12710
Andrei Turtoi, Arnaud Blomme, Delphine Debois, Joan Somja, David Delvaux, Georgios Patsos, Emmanuel Di Valentin, Olivier Peulen, Eugene Nzaramba Mutijima, Edwin De Pauw, Philippe Delvenne, Olivier Detry, Vincent Castronovo, None, Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies Hepatology. ,vol. 59, pp. 924- 934 ,(2014) , 10.1002/HEP.26608
Rebekah L. Gundry, Melanie Y. White, Christopher I. Murray, Lesley A. Kane, Qin Fu, Brian A. Stanley, Jennifer E. Van Eyk, Preparation of Proteins and Peptides for Mass Spectrometry Analysis in a Bottom-Up Proteomics Workflow Current protocols in molecular biology. ,vol. 90, ,(2009) , 10.1002/0471142727.MB1025S88
Huaiyu Mi, Anushya Muruganujan, John T Casagrande, Paul D Thomas, Large-scale gene function analysis with the PANTHER classification system Nature Protocols. ,vol. 8, pp. 1551- 1566 ,(2013) , 10.1038/NPROT.2013.092
R. F. Ozols, Treatment goals in ovarian cancer. International Journal of Gynecological Cancer. ,vol. 15, pp. 3- 11 ,(2005) , 10.1111/J.1525-1438.2005.15351.X
Zhiqin Dai, Jie Yin, Haojie He, Wenrui Li, Chunmei Hou, Xiaohong Qian, Ning Mao, Lingya Pan, Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines Proteomics. ,vol. 10, pp. 3789- 3799 ,(2011) , 10.1002/PMIC.200900685
Sören-Oliver Deininger, Matthias P. Ebert, Arne Fütterer, Marc Gerhard, Christoph Röcken, MALDI Imaging Combined with Hierarchical Clustering as a New Tool for the Interpretation of Complex Human Cancers Journal of Proteome Research. ,vol. 7, pp. 5230- 5236 ,(2008) , 10.1021/PR8005777
Fengming Gong, Xingchen Peng, Zhi Zeng, Ming Yu, Yuwei Zhao, Aiping Tong, Proteomic analysis of cisplatin resistance in human ovarian cancer using 2-DE method Molecular and Cellular Biochemistry. ,vol. 348, pp. 141- 147 ,(2011) , 10.1007/S11010-010-0648-6